Magnetar Financial LLC Sells 434,123 Shares of Encompass Health Co. (NYSE:EHC)

Magnetar Financial LLC cut its stake in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 70.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 177,820 shares of the company's stock after selling 434,123 shares during the quarter. Magnetar Financial LLC owned 0.18% of Encompass Health worth $16,422,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. MassMutual Private Wealth & Trust FSB boosted its position in shares of Encompass Health by 87.8% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock valued at $27,000 after purchasing an additional 137 shares during the period. Avior Wealth Management LLC purchased a new stake in Encompass Health during the third quarter valued at about $40,000. CBIZ Investment Advisory Services LLC boosted its holdings in shares of Encompass Health by 38.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock worth $42,000 after buying an additional 127 shares during the period. Tompkins Financial Corp acquired a new stake in shares of Encompass Health during the fourth quarter valued at approximately $46,000. Finally, V Square Quantitative Management LLC lifted its position in shares of Encompass Health by 43.8% in the 4th quarter. V Square Quantitative Management LLC now owns 581 shares of the company's stock valued at $54,000 after acquiring an additional 177 shares in the last quarter. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, CAO Andrew L. Price sold 5,042 shares of the firm's stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $98.29, for a total value of $495,578.18. Following the sale, the chief accounting officer now directly owns 69,164 shares of the company's stock, valued at approximately $6,798,129.56. This trade represents a 6.79 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 2.10% of the company's stock.

Remove Ads

Wall Street Analysts Forecast Growth

Several research firms have weighed in on EHC. Royal Bank of Canada reiterated an "outperform" rating and set a $110.00 price objective on shares of Encompass Health in a research report on Tuesday, February 11th. StockNews.com upgraded Encompass Health from a "hold" rating to a "buy" rating in a report on Saturday, February 15th. KeyCorp increased their price objective on Encompass Health from $117.00 to $120.00 and gave the stock an "overweight" rating in a research note on Monday, February 10th. William Blair reaffirmed an "outperform" rating on shares of Encompass Health in a research note on Friday, February 7th. Finally, Barclays increased their price target on shares of Encompass Health from $116.00 to $118.00 and gave the stock an "overweight" rating in a research report on Friday, February 7th. Ten analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, Encompass Health currently has a consensus rating of "Buy" and a consensus target price of $107.67.

Encompass Health Stock Up 3.0 %

NYSE EHC traded up $2.89 during trading on Monday, reaching $99.99. The company's stock had a trading volume of 710,770 shares, compared to its average volume of 632,744. The company has a current ratio of 1.05, a quick ratio of 1.04 and a debt-to-equity ratio of 0.84. The stock has a market capitalization of $10.07 billion, a PE ratio of 22.42, a PEG ratio of 2.31 and a beta of 0.92. Encompass Health Co. has a 1-year low of $76.11 and a 1-year high of $105.23. The business has a 50-day moving average price of $98.13 and a 200-day moving average price of $97.20.

Encompass Health (NYSE:EHC - Get Free Report) last released its quarterly earnings data on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. On average, research analysts forecast that Encompass Health Co. will post 4.8 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be given a dividend of $0.17 per share. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $0.68 dividend on an annualized basis and a yield of 0.68%. Encompass Health's payout ratio is currently 15.25%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.